Cabotegravir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cabotegravir and local guidelines before prescribing.
Integrase inhibitor
Mechanism
Integrase strand transfer inhibitor (long-acting injection).
Uses
HIV treatment (with rilpivirine) and pre-exposure prophylaxis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Injection-site reactions, headache, pyrexia.
Interactions
Rifampicin contraindicated.
Contraindications and cautions
Rifampicin use
Monitoring
HIV viral load
Pregnancy and breastfeeding
Used where needed
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Monthly or two-monthly intramuscular injection.
More from the textbook: uses, cautions and other points
- Usual regimen - three drugs : two nucleoside reverse transcriptase inhibitors (NRTIs) plus an integrase inhibitor ; often a single daily tablet . Two-drug regimens (dolutegravir plus lamivudine) are used in selected people (no hepatitis B, no resistance). Long-acting injections (cabotegravir plus rilpivirine every 2 months) are an option …
ID: HIV, viral hepatitis and blood-borne viruses - Long-acting injectable PrEP (cabotegravir) is an emerging option.
Gynaecology: Sexual health - Integrase inhibitors | Dolutegravir , bictegravir , raltegravir, cabotegravir | Well tolerated; insomnia, headache, weight gain ; dolutegravir and bictegravir raise creatinine slightly (block its secretion - not true kidney damage); absorption reduced by antacids, calcium, iron, magnesium - separate doses
ID: HIV, viral hepatitis and blood-borne viruses - Cabotegravir + rilpivirine (injection) | Long-acting every 2 months for suppressed patients.
ID: HIV, viral hepatitis and blood-borne viruses - Integration | Integrase inhibitors ( dolutegravir , bictegravir, cabotegravir) | HIV
Microbiology: Virology - structure, replication and important viral infections - Antiretroviral therapy (ART) - start at diagnosis regardless of CD4 count (usually two NRTIs plus an integrase inhibitor, e.g. bictegravir/emtricitabine/tenofovir alafenamide; long-acting injectable cabotegravir + rilpivirine every 2 months for suppressed patients). Check HLA-B*57:01 before abacavir.
Microbiology: Virology - structure, replication and important viral infections
Where it is discussed in the book
- Gynaecology: Sexual health (1 mention)
- ID: HIV, viral hepatitis and blood-borne viruses (3 mentions)
- Microbiology: Virology - structure, replication and important viral infections (2 mentions)